Bitter Pill

“Sherman also spends a small fortune on litigation—a full 50 per cent of what he invests in research. Generic manufacturers like Apotex live or die by the speed with which they can plunge into the market­place with copycat versions. So they make it their business to shorten the duration that brand name companies hold on to drug monopolies, weighing potential profits against the risk of lawsuits. It’s not unusual for Apotex—probably the country’s biggest litigator—to be engaged in 100 court cases simultaneously.”

 

Geraldine Sherman – Toronto Life – July 2008

Advertisement